Bharat Biotech wants maximum price of covaxin to recover costs
Premium
Emergency Use Authorisation has been granted to two indigenously manufactured vaccines -- SII and Bharat Biotech, and a third vaccine (Sputnik) that while presently manufactured abroad will eventually be manufactured in India.
(REUTERS)
Dr Krishna Ella, CMD, Bharat Biotech, said that he would like to get the maximum price of covaxin to recover all costs, including Rs350 crore spent on clinical trials, in order to have money to work on vaccines for all kinds of infectious diseases
Share Via
Read Full Story
A day after central government allowed sale of covid-19 vaccines in open market, Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech International Ltd, maker of covaxin, on Tuesday said that he would like to get the maximum price to recover all costs, including the ₹350 crore spent on clinical trials, in order to have money to work on vaccines for all kinds of infectious diseases.